Mankind Pharma Q3 net profit rises 9.5% as BSV boost offsets acute weakness
Mankind Pharma Q3 net profit rises 9.5% as BSV boost offsets acute weakness
Mankind Pharma Q3 net profit rises 9.5% as BSV boost offsets acute weakness
Sector
HEALTHCARE
News Type
MARKET
Impact Level
MEDIUM
AI Sentiment
NEUTRAL
Published
09 May 2026
📎 Sources
Moneycontrol | https://www.tradingview.com/news/moneycontrol:523546e81094b:0-mankind-pharma-q3-net-profit-rises-9-5-as-bsv-boost-offsets-acute-weakness/